Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Avastin in PSA Relapse Androgen Independent Prostate Cancer
NCT01656304Phase 2Completed
- Sponsor
- Barbara Ann Karmanos Cancer Institute
- Start
- May 2007
- Primary completion
- Jan 2012
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in prostate cancer (PCa), sponsored by Barbara Ann Karmanos Cancer Institute. Started May 2007; status: completed.
02
Drugs
bevacizumab
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT01656304.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01656304.